ダウンロード数: 203

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
14_0351.pdf405.09 kBAdobe PDF見る/開く
タイトル: 尿路感染症の薬剤耐性とNalidixic Acidの治験について
その他のタイトル: Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections
著者: 牧野, 昌彦  KAKEN_name
著者名の別形: Makino, Masahiko
キーワード: Bacteria/drug effects
Chloramphenicol/pharmacology
Drug Resistance, Microbial
Escherichia coli/drug effects
Humans
Kanamycin/pharmacology
Nalidixic Acid/therapeutic use
Oleandomycin/pharmacology
Streptomycin/pharmacology
Tetracycline/pharmacology
Urinary Tract Infections/drug therapy/microbiology
発行日: Jun-1968
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 14
号: 6
開始ページ: 351
終了ページ: 356
抄録: A total of 282 organisms isolated during the year of 1966 from ambulatory patients with urinary tract infection at the Anjoh Kosei Hospital, Anjoh, were examined for percentage frequency of isolation as well as percentage resistance to a series of eight antibiotics by the bacterial species, for degree of their pathogenicity to urinary tract infection, and for the presence of multiple resistance to antibiotics, For inhibition of the growth of E. coli in vitro, the most effective agents were Nalidixic acid and PanfuranS followed, in order, by kanamycin, cephaloridine, colimycin, streptomycin, chloramphenicol and tetracycline, A clinical trial with the narrow-spectrum antibacterial agent Wintomylon (nalidixic acid) which thus showed the lowest MIC values against E. coli was conducted in a series of 124 patients with urinary tract infection, and the results obtained confirmed its potential usefulness in this disease state.
URI: http://hdl.handle.net/2433/119869
PubMed ID: 4882490
出現コレクション:Vol.14 No.6

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。